Fisher named Siteman executive director of research, business administration
Nick Fisher, an administration expert who has 14 years of experience with academic clinical research and cancer center operations, has been named executive director of research and business administration at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
$3.9 million supports research to turn bacteria into biofuel producers
Researchers at Washington University in St. Louis have received a $3.9 million grant from the Department of Energy (DOE) to develop bacteria that manufacture renewable biofuels — energy sources made from plants or microbes.
Washington University research spurs new WHO guidelines for disabling tropical disease
Research led by the School of Medicine has prompted the World Health Organization (WHO) to issue new treatment guidelines aimed at accelerating global elimination of lymphatic filariasis – a devastating tropical disease.
Kidney disease increases risk of diabetes, study shows
School of Medicine researchers have linked kidney disease to a higher risk of diabetes. They found that the likely cause is elevated urea levels.
Conroy, Fort, Moley honored with 2017 2nd Century awards
Washington University faculty members Glenn C. Conroy and Kelle H. Moley, MD, along with businessman and philanthropist Jeffrey T. Fort, recently were honored with 2017 2nd Century Awards.
Brain networks that help babies learn to walk ID’d
School of Medicine scientists have identified brain networks involved in a baby’s learning to walk — a discovery that eventually may help predict whether some infants are at risk for autism.
Drake receives Baylor alumni award
Bettina Drake, associate professor of surgery at Washington University School of Medicine in St. Louis, was honored with the 2017 Baylor University Distinguished Black Alumni Award.
Alzheimer’s damage in mice reduced with compound that targets APOE gene
School of Medicine researchers have identified a compound that targets the APOE protein in the brains of mice and protects against damage induced by the Alzheimer’s protein amyloid beta.
Clot-busting drugs not recommended for most patients with blood clots
About half of people with blood clots in the deep veins of their legs develop a complication that involves chronic limb pain and swelling, making it difficult for some to walk and perform daily activities. A large-scale clinical trial has shown that a risky, costly procedure to remove such clots fails to reduce the likelihood that patients will develop the debilitating complication.
Obituary: Arthur D. Loewy, professor of anatomy and neuroscience, 74
Arthur DeCosta Loewy, professor of anatomy and of neuroscience at Washington University School of Medicine in St. Louis, died Dec. 2, 2017, of complications related to inflammatory bowel disease and other health issues. He was 74.
View More Stories